Actividades Científicas

Congresos

Resúmenes en congresos:

1.  “SARS Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-LAMM Study on behalf of GELAMM”. Humberto Martínez-Cordero, Camila Peña, Dorotea Fantl, Eloísa Riva. Natalia Paola Schutz, et al. Blood(2020) 136 (Supplement 1): 24-26. https://doi.org/10.1182/blood-2020-142823. 

2.  “Light-chain amyloidosis in Latin America. Diagnosis and frontline treatment”. Riva E, Ranero S, Peña C, Ríos O, Duarte P, Martínez L, Enciso L, Martínez H, Fernández J. 14.6.20. European Hematology Association Annual meeting. EHA Library. Riva E. 06/12/20; 297974; PB2058.

3.  “Real world outcomes in latin-American patients with multiple myeloma under 40 years old”. Martínez-Cordero H, Peña C, Schutz N, Bove V, VillanoF, Osorio R, Chandía M, Beltrán C, Schulz J, Cardemil D, Contreras C, Vergara C, Donoso J, Espinoza M, La Rocca G, López-Vidal H, León P, Roa M, Rojas C, Soto P, Aranda S, Torres V, Ochoa P, Duarte P, Remaggi G, Yantorno S, Corzo A, Zabaljauregui S, Shanley C, Lopresti S, Orlando S, Verri V, Quiroga L, García J, Fernández V, Fantl D, Ramirez J, Molina A, Papilco P, Mite A, Reyes I, Sabando B, Ramirez F, Sossa C, Abello V, Idrobo H, Saavedra D, Quintero G, Gaviria L, Gómez R, Osuna M, Henao A, Tarín L, Cantu O, Gómez-Almaguer D, Itzayana Y, Cruz A, Cantero Y, Ruiz-Argüelles G, Riva E. Blood (2019) 134 (Supplement1): 5508. https://doi.org/10.1182/blood-2019-130987.

4.  “Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers”. Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brener Sabando, MD, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Kenny Galvez, MD, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Raimundo Gazitua, MD, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Macarena Roa, MD, Eloisa Riva, MD Blood (2019) 134 (Supplement_1): 5497. https://doi.org/10.1182/blood-2019-127555.

5.  “Early mortality in Transplant-eligible Multiple Myeloma patients in Latin America. An International Study of GELAMM”. V Bove, C Peña, N Schütz, C Rojas, G Ruiz Argüelles, J Ramirez, L Tarin-Arzaga, P Ochoa, P Duarte, G Remaggi, S Yantorno, P Soto, C Contreras, M Chandía, H López Vidal, A Corzo, S Zabaljauregui, F Ramirez, C Vergara, C Shanley, R Osorio, D Cardemil, J Jerez, F Villano, S Orlando, L Quiroga, C Beltrán, V Verri, D Fantl, E Riva. 17th International Myeloma Workshop, September 12-15, 2019 Abstract Book: 307-308.

6.  “Oucome in transplant-eligible patients with multiple mieloma in Latin America. An international study of GELAMM”. C Peña, N Schutz, V Bove, F Villano, R Osorio, M Chandía, D Cardemil, C Contreras, C Contreras, J Donoso, M Espinoza, G La Rocca, H López Vidal, C Rojas, P Soto, P Ochoa, P Duarte, G Remaggi, S Yantorno, A Corzo, S Zabaljauregui, C Shanley, S Lopresti, S Orlando, V Verri, L Quiroga, C Alen García, V Fernández, D Fantl, E Riva. European Hematology Association Congress. Amsterdam, Holanda. Junio 2019.

7.  “Epidemiological and clinical characteristics of Monoclonal Gammopathy of renal significance (MGRS) related lesions in Latin America, a study of the GELAMM group”. C Peña, N Schutz, E Riva, R Valjalo, A Majlis, H López-Vidal, V Lois, D Zamora, P Ochoa, C Shanley, J T Gonzalez, D Fantl, G Correa, J Ramirez, P Mur, G Silva, V Verri, C Rojas, K Escobar, G Glavic, G P. Méndez. 4th IKMG international meeting. 23-24 mayo, 2019. Montreal, Canadá.

8.  “Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America.” Riva E, Peña C,Schütz N, Villano F, Ruiz-Argüelles GJ, Navarro JR, Bove V, Bujan W, Rodriguez A, Andino L, Rojas C, López-Vidal H, Fantl D, on behalf of GELAMM (Grupo de Estudio LatinoAmericano de Mieloma Múltiple). American Society of Hematology. Annual Meeting. San Diego 2018.